Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Filings indexed 1,395 across all filing types
Latest filing 2024-11-21 Board/Management Inform…
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 20, 2024, by IDEXX Laboratories, Inc. The content focuses on the departure and appointment of key executives, specifically the retirement of the CFO and the appointment of a new CFO. It details the roles, responsibilities, and compensation of the new CFO. There are no financial statements or detailed financial performance data included. The primary subject is changes in senior management and board-related information. According to the filing definitions, announcements of changes in the company's board of directors or senior management fall under Board/Management Information (MANG). The document is not an annual or quarterly report, nor an earnings release or other financial report. Therefore, the correct classification is MANG with high confidence.
2024-11-21 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-11-12 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated November 8, 2024, by IDEXX Laboratories, Inc. The key content is the resignation of a board member, Jonathan W. Ayers, including details about his tenure and the reduction in board size. There are no financial statements or earnings data presented. The primary subject is a change in the company's board of directors. According to the filing definitions, announcements of changes in the company's board or senior management fall under Board/Management Information (MANG). The document length is 4652 characters, which is sufficient to contain substantive information about the board change, not just a brief announcement. Therefore, the correct classification is MANG with high confidence.
2024-11-12 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events or material definitive agreements. The text describes an entry into a material definitive agreement (amendments to supply agreements) and references the original agreements filed as exhibits to the prior Annual Report (Form 10-K). The document is 4399 characters long, which is relatively short and focused on a specific event rather than comprehensive financial data or management discussion. It is not an Annual Report, Interim Report, Earnings Release, or any other detailed financial report. It is also not a report publication announcement or certification. The content fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a material contract amendment without substantive financial statements or detailed analysis. Therefore, the appropriate classification is Regulatory Filings (RNS) with high confidence.
2024-11-06 English
Major Shareholding Notification 2024
Major Shareholding Notification
2024-11-04 English
10-Q
Interim / Quarterly Report Q3 2024
2024-10-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.